Combivir
Product Images NDC 21695-846

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Combivir (NDC 21695-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamivudine Chemical Structure (D8540843 055c 47fb 9cff 81e64b1d41c3 01)

FDA Label Image

Zidovudine Chemical Structure (D8540843 055c 47fb 9cff 81e64b1d41c3 02)

FDA Label Image

Combivir 150mg/300mg (D8540843 055c 47fb 9cff 81e64b1d41c3 03)

Combivir 150mg/300mg (D8540843 055c 47fb 9cff 81e64b1d41c3 03)
This appears to be a product label for a medication. The product name is not available, but its ID is PCOB4606. Each tablet contains 150mg of Lamivudine and 300mg of an unknown substance. The label suggests that the product is prescription-only (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.